Clinical Trial Update: Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating vilazodone for generalized anxiety disorder assessing safety, efficacy, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Vilazodone (vilazodone)

Snippet

Sponsor: Forest Laboratories | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-12-18